11C-Choline
11C-Choline is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer
[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients
Characterizing LAM With 11C-Choline PET/CT
A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland
Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography
Clinical Trials (7)
PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer
[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients
Characterizing LAM With 11C-Choline PET/CT
A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland
Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography
Carbon-11 Labeled Sarcosine in Prostate Cancer
Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7